Lifepoint Health and Midi Health have announced a collaboration to provide virtual care to women across the US who are experiencing symptoms of perimenopause and menopause. The partnership aims to improve the quality of care for this segment of women’s health by using telemedicine to serve patients in Lifepoint’s facilities. This will make high-quality virtual care accessible to thousands of women across…
Madorra has developed a non-invasive, home-use therapeutic ultrasound device that can potentially treat vaginal dryness in postmenopausal women with vulvovaginal atrophy (VVA). This condition affects millions of women in the US and is a component of genitourinary syndrome of menopause (GSM). Madorra’s Pilot 1 clinical study, which was published in Menopause, the Journal of the North American Menopause Society (NAMS), showed that…
Astellas Pharma has purchased a 30-second commercial during Super Bowl LVII to raise awareness about vasomotor symptoms (VMS), which are hot flashes and night sweats associated with menopause. The commercial features actress Carmella Riley asking women on the street about their experiences with VMS. Astellas has a new drug called fezolinetant in the works which treats moderate-to-severe VMS symptoms and has been…
The Berlin-based femtech company XbyX – Women in Balance, founded in 2019 by Peggy Reichelt and Monique Leonhardt, is a D2C platform for women in midlife offering scientifically founded, holistic solutions for menopause and healthy aging. After growing its customer base to over 50,000 women and doubling its revenue in 2022, the company has now announced a 7-figure pre-series A financing round,…
Menopause is defined as the final menstrual period and is typically confirmed after a woman has missed her period for 12 consecutive months. Most women experience menopause between ages 40 and 58. An estimated 45 million women in the U.S. are approaching or in menopause, which results in a decrease in estrogen and other hormones. Hot flashes, vaginal dryness and loss of bone density are…
A couple of weeks ago Haleon announced the third cohort of its Re/Wire Health Studio accelerator program. The program’s goal is to discover and scale early-stage consumer health and tech innovators. Participants have now been selected and include startups with innovative solutions in oral health, behavioral health, micorbiome science, and also women’s health. Founders at the six selected companies will benefit from…
Healthcare incubator and innovation hub MATTER, alongside Astellas Pharma US, Walgreens, BayCare, Parkview Health, University of Chicago Medicine and Capita3 has selected 11 startups who are joining the inaugural cohort of 51 Labs, the new women’s health accelerator program. Matter announced its new 51 Labs program only a few weeks ago with the goal to address the gap in women’s health innovation…
Northwell Holdings and Aegis Ventures are teaming up to launch Upliv, a women’s virtual care start-up that aims to raise the bar for clinical menopause support. Upliv will partner with employers to offer virtual telemedicine services and whole-person care to employees experiencing perimenopause and menopause symptoms. Initially, Upliv will offer services to select nurses through a pilot program at Northwell Health, followed by an expected enterprise-wide…
